OAB-048: An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study

Clinical Lymphoma Myeloma and Leukemia(2022)

引用 0|浏览5
暂无评分
关键词
multiple myeloma,belantamab mafodotin,carfilzomib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要